1. Home
  2. HNI vs PGEN Comparison

HNI vs PGEN Comparison

Compare HNI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

HOLD

Current Price

$48.05

Market Cap

3.4B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNI
PGEN
Founded
1944
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
HNI
PGEN
Price
$48.05
$6.39
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
★ $71.00
$13.65
AVG Volume (30 Days)
453.7K
★ 4.6M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
★ 3.11%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.17
0.03
Revenue
★ $2,839,000,000.00
$230,981,000.00
Revenue This Year
$110.77
$2,365.68
Revenue Next Year
$3.54
$85.75
P/E Ratio
$266.35
★ $220.17
Revenue Growth
★ 12.37
N/A
52 Week Low
$28.93
$3.04
52 Week High
$52.79
$8.98

Technical Indicators

Market Signals
Indicator
HNI
PGEN
Relative Strength Index (RSI) 55.11 36.29
Support Level $46.92 $6.08
Resistance Level $48.24 $7.44
Average True Range (ATR) 1.43 0.44
MACD -0.02 -0.17
Stochastic Oscillator 77.59 2.37

Price Performance

Historical Comparison
HNI
PGEN

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: